These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 20877368

  • 1. In vitro activity of two old antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus.
    Yu XH, Song XJ, Cai Y, Liang BB, Lin DF, Wang R.
    J Antibiot (Tokyo); 2010 Nov; 63(11):657-9. PubMed ID: 20877368
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of minocycline combined with fosfomycin against clinical isolates of methicillin-resistant Staphylococcus aureus.
    Sun C, Falagas ME, Wang R, Karageorgopoulos DE, Yu X, Liu Y, Cai Y, Liang B, Song X, Liu Z.
    J Antibiot (Tokyo); 2011 Aug; 64(8):559-62. PubMed ID: 21772306
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of fosfomycin in combination with linezolid against clinical isolates of methicillin-resistant Staphylococcus aureus.
    Xu-hong Y, Falagas ME, Dong W, Karageorgopoulos DE, De-feng L, Rui W.
    J Antibiot (Tokyo); 2014 May; 67(5):369-71. PubMed ID: 24517925
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of daptomycin combinations with rifampicin, gentamicin, fosfomycin and fusidic acid against MRSA strains.
    Aktas G, Derbentli S.
    J Glob Antimicrob Resist; 2017 Sep; 10():223-227. PubMed ID: 28735049
    [Abstract] [Full Text] [Related]

  • 5. In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus.
    Sahuquillo Arce JM, Colombo Gainza E, Gil Brusola A, Ortiz Estévez R, Cantón E, Gobernado M.
    Rev Esp Quimioter; 2006 Sep; 19(3):252-7. PubMed ID: 17099793
    [Abstract] [Full Text] [Related]

  • 6. [In vitro study of the cefamandole-fosfomycin combination against methicillin-resistant staphylococci].
    Fosse T, David MF, Duluc F, Darmusey D, Tamalet C, Toga B.
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):528-31. PubMed ID: 6462742
    [Abstract] [Full Text] [Related]

  • 7. In vitro antimicrobial findings for fusidic acid tested against contemporary (2008-2009) gram-positive organisms collected in the United States.
    Jones RN, Mendes RE, Sader HS, Castanheira M.
    Clin Infect Dis; 2011 Jun; 52 Suppl 7():S477-86. PubMed ID: 21546624
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of nasal carriage of methicillin-resistant Staphylococcus aureus and its antibiotic susceptibility pattern in healthcare workers at Namazi Hospital, Shiraz, Iran.
    Askarian M, Zeinalzadeh A, Japoni A, Alborzi A, Memish ZA.
    Int J Infect Dis; 2009 Sep; 13(5):e241-7. PubMed ID: 19269873
    [Abstract] [Full Text] [Related]

  • 9. [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci].
    Picazo JJ, Betriu C, Rodríguez-Avial I, Culebras E, López F, Gómez M, Grupo VIRA.
    Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):13-6. PubMed ID: 19406529
    [Abstract] [Full Text] [Related]

  • 10. Activity of fusidic acid against extracellular and intracellular Staphylococcus aureus: influence of pH and comparison with linezolid and clindamycin.
    Lemaire S, Van Bambeke F, Pierard D, Appelbaum PC, Tulkens PM.
    Clin Infect Dis; 2011 Jun; 52 Suppl 7():S493-503. PubMed ID: 21546626
    [Abstract] [Full Text] [Related]

  • 11. [Investigation of the Antibacterial Synergistic Activity of Fosfomycin-Teicoplanin Combination in Methicillin-Resistant Staphylococcus aureus Strains Isolated from Various Clinical Sample].
    Biçer RT, Özekinci T, Koçoğlu ME.
    Mikrobiyol Bul; 2024 Apr; 58(2):113-124. PubMed ID: 38676580
    [Abstract] [Full Text] [Related]

  • 12. Antimicrobial susceptibility of Staphylococcus aureus isolated from children with impetigo in China from 2003 to 2007 shows community-associated methicillin-resistant Staphylococcus aureus to be uncommon and heterogeneous.
    Liu Y, Kong F, Zhang X, Brown M, Ma L, Yang Y.
    Br J Dermatol; 2009 Dec; 161(6):1347-50. PubMed ID: 19754868
    [Abstract] [Full Text] [Related]

  • 13. In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals.
    Norazah A, Lim VK, Rohani MY, Kamel AG.
    Med J Malaysia; 2005 Oct; 60(4):411-5. PubMed ID: 16570701
    [Abstract] [Full Text] [Related]

  • 14. Emergence of vancomycin-resistant Staphylococcus aureus identified in the Tlemcen university hospital (North-West Algeria).
    Rebiahi SA, Abdelouahid DE, Rahmoun M, Abdelali S, Azzaoui H.
    Med Mal Infect; 2011 Dec; 41(12):646-51. PubMed ID: 22033230
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the activity of fusidic acid tested against contemporary Gram-positive clinical isolates from the USA and Canada.
    Pfaller MA, Castanheira M, Sader HS, Jones RN.
    Int J Antimicrob Agents; 2010 Mar; 35(3):282-7. PubMed ID: 20036520
    [Abstract] [Full Text] [Related]

  • 16. Efforts to support the development of fusidic acid in the United States.
    Fernandes P, Pereira D.
    Clin Infect Dis; 2011 Jun; 52 Suppl 7():S542-6. PubMed ID: 21546632
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of Fosfomycin Resistance in Methicillin-Resistant Staphylococcus aureus Isolated from Patients in a University Hospital in China from 2013 to 2015.
    Wu D, Chen Y, Sun L, Qu T, Wang H, Yu Y.
    Jpn J Infect Dis; 2018 Jul 24; 71(4):312-314. PubMed ID: 29709971
    [Abstract] [Full Text] [Related]

  • 18. [In vitro effect of combinations of netilmicin and amikacin with fosfomycin and pefloxacin on 31 strains of heterogeneous methicillin- resistant Staphylococcus aureus].
    David C, Chaste A, Saison C, Combremont AG.
    Pathol Biol (Paris); 1988 Jun 24; 36(5 Pt 2):608-12. PubMed ID: 3054735
    [Abstract] [Full Text] [Related]

  • 19. Methicillin- and gentamicin-resistant Staphylococcus aureus: susceptibility to fosfomycin, cefamandole, N-formimidoyl-thienamycin, clindamycin, fusidic acid and vancomycin.
    Graninger W, Leitha T, Breyer S, Francesconi M, Lenz K, Georgopoulos A.
    Drugs Exp Clin Res; 1985 Jun 24; 11(1):23-7. PubMed ID: 3869801
    [Abstract] [Full Text] [Related]

  • 20. Synergy between gemifloxacin and trimethoprim/sulfamethoxazole against community-associated methicillin-resistant Staphylococcus aureus.
    Leonard SN, Kaatz GW, Rucker LR, Rybak MJ.
    J Antimicrob Chemother; 2008 Dec 24; 62(6):1305-10. PubMed ID: 18801920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.